Prevalence of new psychoactive substances: A retrospective study in hair

Drug Testing and Analysis

Volumn 4, Issue 6, 2012, Pages 402-408

  Rust, Kristina Yasmin ^a   Baumgartner, Markus R ^a   Dally, Annika M ^a   Kraemer, Thomas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Hair analysis; LC MS; New drugs; Prevalence

Indexed keywords

AMINES; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

CATHINONE; DESIGNER DRUGS; HAIR ANALYSIS; KETAMINE; LC-MS; METHYLPHENIDATE; NEW DRUG; PLANT FOODS; PREVALENCE; REANALYSIS;

ELECTROSPRAY IONIZATION;

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 FLUOROAMPHETAMINE; 4' METHYLMETHCATHINONE; AMPHETAMINE; BENZYLPIPERAZINE; BUTYLONE; CATHINONE; ETHYLONE; KETAMINE; METACHLOROPHENYLPIPERAZINE; METHCATHINONE; METHYLENEDIOXYPYROVALERONE; METHYLONE; METHYLPHENIDATE; PSYCHOTROPIC AGENT; TRAZODONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG SCREENING; ELECTROSPRAY; HAIR; HUMAN; LIQUID CHROMATOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TANDEM MASS SPECTROMETRY;

EID: 84863085600     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1338     Document Type: Article

References (29)

1. S. D. Brandt, S. Freeman, H. R. Sumnall, F. Measham, J. Cole. Analysis of NRG 'legal highs' in the UK: Identification and formation of novel cathinones. Drug Test. Analysis 2011, 3, 569.
2. S. D. Brandt, H. R. Sumnall, F. Measham, J. Cole. Analyses of second-generation 'legal highs' in the UK: Initial findings. Drug Test. Analysis 2010, 2, 377.
3. M. Bovens, M. Schlaepfer. Designer drugs/Research Chemicals/Legal Highs - A survey of recent seizures and an attempt to a more effective hnadling from a Swiss perspective. Toxichem. Krimtech. 2011, 78, 167.
4. Available at: [29 November 2011].
5. Available at: [29 November 2011].
6. R. F. Staack, H. H. Maurer. Metabolism of designer drugs of abuse. Curr. Drug Metab. 2005, 6, 259.
7. M. H. Baumann, R. D. Clark, A. G. Budzynski, J. S. Partilla, B. E. Blough, R. B. Rothman. N-substituted piperazines abused by humans mimic the molecular mechanism of 3, 4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). Neuropsychopharmacology 2005, 30, 550.
8. J. Rohrich, J. Becker, T. Kaufmann, S. Zorntlein, R. Urban. Detection of the synthetic drug 4-fluoroamphetamine (4-FA) in serum and urine. Forensic Sci. Int. 2011, DOI: 10.1016/j.forsciint.2011.04.004.
9. M. R. Meyer, H. H. Maurer. Metabolism of designer drugs of abuse: An updated review. Curr. Drug Metab. 2010, 11, 468.
10. M. H. Baumann, M. A. Ayestas Jr., J. S. Partilla, J. R. Sink, A. T. Shulgin, P. F. Daley, et al. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 2011, DOI: 10.1038/npp.2011.304.
11. P. Kriikku, L. Wilhelm, O. Schwarz, J. Rintatalo, I. Ojanperae, E. Vuori, et al. Methylenedioxypyrovalerone (MDPV) in Finland. Toxichem. Krimtech. 2011, 78, 293.
12. L. T. Wu, D. J. Pilowsky, W. E. Schlenger, D. M. Galvin. Misuse of methamphetamine and prescription stimulants among youths and young adults in the community. Drug Alcohol Depend. 2007, 89, 195.
13. S. E. McCabe, J. R. Knight, C. J. Teter, H. Wechsler. Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction 2005, 100, 96.
14. C. Senn, A. Bucheli, M. Schaub, R. Stohler. [Club drugs]. Ther. Umsch. 2007, 64, 109.
15. P. Dillon, J. Copeland, K. Jansen. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend. 2003, 69, 23.
16. C. J. Morgan, H. V. Curran. Ketamine use: A review. Addiction 2012, 107, 27.
17. J. C. Lin, R. K. Jan, R. R. Kydd, B. R. Russell. Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination. Drug Test. Analysis 2011, 3, 582.
18. H. A. Spiller, M. L. Ryan, R. G. Weston, J. Jansen. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin. Toxicol. (Phila.) 2011, 49, 499.
19. P. I. Dargan, S. Albert, D. M. Wood. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. Q.J.M. 2010, 103, 875.
20. P. I. Dargan, R. Sedefov, A. Gallegos, D. M. Wood. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test. Analysis 2011, 3, 454.
21. J. P. Kelly. Cathinone derivatives: A review of their chemistry, pharmacology and toxicology. Drug Test. Analysis 2011, 3, 439.
22. M. R. Baumgartner, R. Guglielmello, M. Fanger, T. Kraemer. Analysis of drugs of abuse in hair: Evaluation of the immunochemical method VMA-T vs. LC-MS/MS or GC-MS. Forensic Sci. Int. 2011, DOI: 10.1016/j.forsciint.2011.08.025.
23. K. Y. Rust, M. R. Baumgartner, N. Meggiolaro, T. Kraemer. Detection and validated quantification of 21 benzodiazepines and 3 "z-drugs" in human hair by LC-MS/MS. Forensic Sci. Int. 2011, DOI: 10.1016/j.forsciint.2011.07.052.
24. W. Weinmann. Available at: [24 February 2012].
25. W. Weinmann Available at: [24 February 2012].
26. F. Sporkert, F. Pragst, R. Bachus, F. Masuhr, L. Harms. Determination of cathinone, cathine and norephedrine in hair of Yemenite khat chewers. Forensic Sci. Int. 2003, 133, 39.
27. H. Z. Rofael, M. S. Abdel-Rahman. Development and validation of a high-performance liquid chromatography method for the determination of cocaine, its metabolites and ketamine. J. Appl. Toxicol. 2002, 22, 123.
28. M. Martin, J. F. Muller, K. Turner, M. Duez, V. Cirimele. Evidence of mephedrone chronic abuse through hair analysis using GC/MS. Forensic Sci. Int. 2011, DOI: 10.1016/j.forsciint.2011.10.016.
29. S. A. Shah, N. I. Deshmukh, J. Barker, A. Petroczi, P. Cross, R. Archer, et al. Quantitative analysis of mephedrone using liquid chromatography tandem mass spectroscopy: Application to human hair. J. Pharm. Biomed. Anal. 2012, 61, 64.